Related references
Note: Only part of the references are listed.Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling
Eric Dumas de la Roque et al.
PLOS ONE (2017)
SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn
Anick Berard et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study
H. Nakanishi et al.
JOURNAL OF PERINATOLOGY (2016)
Exercise Reduces Lung Fibrosis Involving Serotonin/Akt Signaling
Paulo Rogerio Pereira et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2016)
Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy
Ulrika Norby et al.
PEDIATRICS (2016)
Early Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasia
Peter M. Mourani et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Crucial requirement of ERK/MAPK signaling in respiratory tract development (vol 141, pg 3197, 2015)
Olivier Boucherat et al.
DEVELOPMENT (2015)
PTEN regulates lung endodermal morphogenesis through MEK/ERK pathway
Yiming Xing et al.
DEVELOPMENTAL BIOLOGY (2015)
Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension
Cassidy Delaney et al.
PEDIATRIC RESEARCH (2015)
The role of serotonin and its receptors in activation of immune responses and inflammation
M. S. Shajib et al.
ACTA PHYSIOLOGICA (2015)
Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension
Eva Nozik-Grayck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Tissue transglutaminase promotes serotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells
Krishna Penumatsa et al.
CELLULAR SIGNALLING (2014)
Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis
Sophie Grigoriadis et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn
Cassidy Delaney et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension
B. D. Stuart et al.
JOURNAL OF PERINATOLOGY (2013)
Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension
Matthew Thomas et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Ozone Exposure Alters Serotonin and Serotonin Receptor Expression in the Developing Lung
Shannon R. Murphy et al.
TOXICOLOGICAL SCIENCES (2013)
Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats
Yvonne P. de Visser et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α
A. Charlotte P. Sewing et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia
Jen-Ruey Tang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Role of serotonin in angiogenesis: Induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice
Masaaki Iwabayashi et al.
ATHEROSCLEROSIS (2012)
Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats
Saurabh Bharti et al.
FEBS LETTERS (2012)
Gene Therapy by Targeted Adenovirus-mediated Knockdown of Pulmonary Endothelial Tph1 Attenuates Hypoxia-induced Pulmonary Hypertension
Ian Morecroft et al.
MOLECULAR THERAPY (2012)
Prospective Analysis of Pulmonary Hypertension in Extremely Low Birth Weight Infants
Ramachandra Bhat et al.
PEDIATRICS (2012)
Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries
Helle Kieler et al.
BRITISH MEDICAL JOURNAL (2012)
Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus
Cassidy Delaney et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation
J. L. Slaughter et al.
JOURNAL OF PERINATOLOGY (2011)
Antagonist Functional Selectivity: 5-HT2A Serotonin Receptor Antagonists Differentially Regulate 5-HT2A Receptor Protein Level In Vivo
Prem N. Yadav et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension
Ian Morecroft et al.
CARDIOVASCULAR RESEARCH (2010)
Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data
M. Reis et al.
PSYCHOLOGICAL MEDICINE (2010)
Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
Hyo Soon An et al.
Korean Circulation Journal (2010)
The Expanded Biology of Serotonin
Miles Berger et al.
ANNUAL REVIEW OF MEDICINE (2009)
Serotonin and pulmonary hypertension-from bench to bedside?
Margaret R. MacLean et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Pulmonary hypertension: therapeutic targets within the serotonin system
Y. Dempsie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn
Bengt Kallen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Heterogeneity in 5-HT-induced contractile and proliferative responses in rat pulmonary arterial bed
L. Rodat-Despoix et al.
JOURNAL OF VASCULAR RESEARCH (2008)
Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: Clinical features and outcomes in the surfactant era
Ekta Khemani et al.
PEDIATRICS (2007)
Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin
Min Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Serotoninergic receptors on human airway epithelial cells
Hans Bayer et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension
Ian Morecroft et al.
HYPERTENSION (2007)
Cross talk between endothelial and smooth muscle cells in pulmonary hypertension - Critical role for serotonin-induced smooth muscle hyperplasia
S Eddahibi et al.
CIRCULATION (2006)
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn
CD Chambers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
5-Hydroxytryptamine receptors in the human cardiovascular system
Alberto J. Kaumann et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease
A Lawrie et al.
CIRCULATION RESEARCH (2005)
Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin
YL Liu et al.
CIRCULATION RESEARCH (2004)
Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats
E Hironaka et al.
CARDIOVASCULAR RESEARCH (2003)
Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia
P Ray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of GATA-4 by serotonin in pulmonary artery smooth muscle cells
YJ Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Serotonin is a novel survival factor of cardiomyocytes:: mitochondria as a target of 5-HT2B-receptor signaling
CG Nebigil et al.
FASEB JOURNAL (2003)
Synthesis of serotonin by a second tryptophan hydroxylase isoform
DJ Walther et al.
SCIENCE (2003)
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
JM Launay et al.
NATURE MEDICINE (2002)
Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure
TD Le Cras et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons
WM Maniscalco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension -: Converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B/1D-receptor antagonist GR127935
A Keegan et al.
CIRCULATION RESEARCH (2001)
Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia
AJ Bhatt et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene
S Eddahibi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: Cross-talk with tyrosine kinase pathways
CG Nebigil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
